*Correspondence: Daiji Kawanami, [email protected] This article was submitted to Renal Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Retatrutide has not received marketing authorisation from the MHRA and is not approved for clinical use in the UK
This is a way to get the peptides in the market and produce revenue off them without having the FDA legality behind it, says Chammout
For a GLP-1 molecule taken by mouth to reach its target, it must first pass through the stomach, where hydrochloric acid and peptidase enzymes cleave these amino acid bonds
This is especially important for older adults, patients with cognitive considerations, or those managing multiple medications where temperature-sensitive storage adds complexity to daily routines
Maja explains why these treatments are not ideal for patients with body art in the area being addressed